# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-23-007422
Filing Date
2023-11-14
Accepted
2023-11-14 16:15:42
Documents
53
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | titanpharma_10q.htm iXBRL | 10-Q | 625859
2 | EXHIBIT 10.4 | titanpharma_ex10-4.htm | EX-10.4 | 146335
3 | EXHIBIT 31.1 | titanpharma_ex31-1.htm | EX-31.1 | 15179
4 | EXHIBIT 32.1 | titanpharma_ex32-1.htm | EX-32.1 | 7421
| Complete submission text file | 0001829126-23-007422.txt |  | 3728511

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ttnp-20230930.xsd | EX-101.SCH | 30819
6 | XBRL CALCULATION FILE | ttnp-20230930_cal.xml | EX-101.CAL | 43800
7 | XBRL DEFINITION FILE | ttnp-20230930_def.xml | EX-101.DEF | 106746
8 | XBRL LABEL FILE | ttnp-20230930_lab.xml | EX-101.LAB | 255817
9 | XBRL PRESENTATION FILE | ttnp-20230930_pre.xml | EX-101.PRE | 200594
47 | EXTRACTED XBRL INSTANCE DOCUMENT | titanpharma_10q_htm.xml | XML | 464026

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 231406469
SIC: 2836 Biological Products, (No Diagnostic Substances)